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Abstract
Both food- and environmentally-related allergies are a continually growing health problem, particularly
in the western world. The exact causes and the additional environmental and social factors that play a
role in the onset of these illnesses are still poorly understood. While sufferers of allergy remain a
minority in society, the reduction of their quality of life and the financial consequences for society as a
whole are of major significance. Allergy is an illness that confronts the sufferer on a daily basis with his
or her life style limitations. The direct and indirect annual costs to society (medical care, sick leave, loss
of earnings, reduced productivity) are already running well into billions of euros. A complicating factor
is that there are many kinds of allergy, with many different causes, requiring several approaches for
treatment. There is no single solution. Much social and scientific research is still needed to generate
additional knowledge required to determine a suitable multidisciplinary strategy for the long-term tack-
ling of this problem. Input from a wide range of sources, including social scientists, medics, agrono-
mists and immunologists, is essential to fully assess the situation and to assist in determining long-
term policy decisions at a national level. This multidisciplinarity calls for broad support from different
sections of government, industry and societal bodies to achieve the desired goal of reversing the rise in
the number of allergy sufferers, preferably through prevention rather than cure. In this article we pres-
ent the most salient items from the presentations and discussions of a workshop on the agronomic
approaches to allergy prevention, recently held in the Netherlands.
Additional keywords: hay fever, food allergy, oral allergy syndrome, coeliac disease
Introduction
During the last three decades, the prevalence of allergy has increased significantly
both in number of cases and extent of individual cases. Allergy has been called ‘the
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epidemic of the 20th century’ (Anon., 1997). Various allergic responses can be distin-
guished of which asthma, rhinitis, eczema and food allergy are the most common
ones. These types of allergy are so-called IgE (Immunoglobulin type E) -mediated aller-
gies, which are different from cell-mediated allergies, prominently typified by e.g.
coeliac disease, or gluten intolerance. 
Currently, most attention is being paid to medical treatment of allergic patients.
However, there is a growing awareness that prevention of allergy deserves much more
attention. Compared with treatment, prevention during the pre-medical phase will be
much more effective in reducing the costs of health care and in improving the
patients’ quality of life. In the light of this, several research initiatives have recently
been started, financed by the Dutch Ministry of Agriculture, Nature and Food Quality,
and by Wageningen University and Research Centre. Allergy prevention involves many
aspects of society and therefore needs a multidisciplinary approach, with integrated
and well co-ordinated activities in the fields of research, education and communica-
tion. This has only been recently recognized and is the reason behind the establish-
ment of e.g. the Allergy Consortium Wageningen (ACW). 
The ACW approach is characterized by its strong and unique focus on allergy
prevention through a source-based approach, which includes the development of inte-
grated and multidisciplinary strategies for allergy prevention and management during
the pre-medical phase. The strategies chosen are directed towards the control of aller-
gens both in food and the environment. Basic activities for strategy development are
research, education, and information transfer related to primary production (plant,
animal), food technology and food production chains, the living and occupational envi-
ronment, as well as societal aspects (related to patients, consumers and governmental
and industrial stakeholders). 
To discuss experiences and opinions on allergy in an agronomic context a work-
shop was organized in 2003 within the framework of the research programme ‘Plant
Compounds and Health’ financed by the Dutch Ministry of Agriculture, Nature and
Food Quality (LNV-DWK 408). The workshop was attended by representatives from
about 40 different organizations, including three ministries, medical and agricultural
research institutes, patient and consumer organizations, pharmaceutical and food
industries, and journalists. Presentations were given on immunological research,
patient concerns, the viewpoint of the food industry and speciality markets, macro-
economic aspects, and an overview of a recently started research programme on
approaches to allergy prevention in an agronomic context. Finally, the workshop
participants discussed a number of statements concerning allergy prevention from
different angles of society. The results of this workshop are embodied in this article. 
What is allergy?
Allergy includes all excessive reactions of the immune system to compounds that are
normally tolerated by the human body. Usually, when the immune system for the first
time comes into contact with compounds – especially proteins – that can elicit an
immune response, such compounds prime the immune system. These compounds or
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‘antigens’ can originate from the living environment (airborne from small arthropods
such as dust mites, dandruff from pets, pollen), from plant- and animal-derived foods,
or from materials coming into direct contact with the skin (e.g. latex). The human
immune system will react to these antigens through the production of antibodies
(immunoglobulins (Ig) of various types) that are highly antigen-specific. Frequent
contact with such antigens generally results in tolerance of the immune system to the
antigen, i.e., the immune system no longer considers these antigens as a threat to the
body. So tolerance refers to a state of unresponsiveness in which the production of
antibodies is not stimulated. 
However, many individuals have a specific genetic predisposition that, in combina-
tion with certain environmental factors, results in this state of unresponsiveness fail-
ing to occur. Such people are called ‘atopic’ and have increased concentrations of a
certain antibody (IgE) in their serum. In these cases, contact with specific antigens
results in sensitization, which can lead to the production of specific antibodies against
a normally harmless antigen. Their general health may quickly become affected and
the person becomes ‘allergic’. The word allergy means ‘altered reactivity’ (allos, differ-
ent; ergon, work) and allergy can be considered as a false alarm of the immune system.
The antigen has become an allergen and the antigens then become responsible for the
occurrence of the inflammatory symptoms typical of most allergic reactions.
Allergen exposure in the nose, eyes or frontal and nasal sinuses will result in rhini-
tis. An example of such a reaction is hay fever but similar symptoms may also result
from proteins in animal dandruff, hairs and feathers. Exposure of allergens to the skin
can cause eczema (dermatitis), which is a long-lasting inflammation of the skin cells.
In the case of asthma, the bronchial tubes and lungs become inflamed, which,
through swelling of the mucous epithelium, results in bronchial stricture and poten-
tially life-threatening respiratory problems. Responses of the digestive tract, resulting
from contact with food allergens, can cause diarrhoea and vomiting. In some cases,
like the nut allergies, this can rapidly result in anaphylaxis, an acute and potentially
fatal reaction. A specific and commonly occurring case of food allergy is the ‘oral aller-
gy syndrome’ (OAS). Itching and swelling of the mouth and throat region as caused
for instance by fresh fruits, vegetables and spices are typical of this type of food aller-
gy. This form of allergy is generally associated with hay fever caused by pollen from
trees, grasses and certain weeds. Both pollen and the foodstuffs concerned contain
similar proteins that cause the allergic reaction. This phenomenon is called allergenic
cross-reactivity. OAS can also occur as a response to true food allergens as in the case
of groundnut (De Leon et al., 2003).
Coeliac disease
Coeliac disease (CD) is a chronic disorder of the small intestine resulting from a cell-
mediated allergy. The intestinal epithelium becomes flattened, leading to poor absorp-
tion of nutrients. The clinical spectrum varies widely and includes abdominal pain,
diarrhoea, mal-absorption and poor growth. CD can lead to more serious complica-
tions, like osteoporosis, infertility, miscarriage, low birth weight of children born to
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mothers suffering from CD, non-Hodgkin’s lymphoma and dermatitis herpetiformis.
The factors that determine or influence this extremely heterogeneous phenotype are
unknown. CD is caused by an inflammatory T-cell response to gluten, a ubiquitous
family of dietary proteins from wheat, barley and rye. Gluten molecules are degraded
in the intestine and the breakdown products can then set off a cascade of reactions
that result in an inflammatory response causing flattening of the villi in the small
intestine (Sollid, 2002). A conservative estimate of the prevalence of CD in Europe
and the USA is about 0.5% of the population. Several epidemiological investigations
show a highly uniform prevalence of 1 in 130 to 1 in 300 amongst all populations of
European descent. Studies have shown that the number of undiagnosed cases in some
countries may be over 7 times more than is currently officially recognized (Czismadia
et al., 1999). Moreover, the prevalence of CD in non-European populations also seems
strongly underestimated. It is generally accepted that CD affects people of all racial
origins and even in those clinically silent cases of CD, significant nutritional deficien-
cies may occur and go unrecognized. Early diagnosis will considerably reduce the risk
of development of CD-associated diseases such as those listed above. Presenting CD
symptoms appears to be modified by factors like dietary gluten load and the age at
which an individual is first exposed to gluten. 
Increase of allergy occurrence
Although the genetic predisposition to atopy and atopy-related allergies is considerable
and possibly still increasing, it cannot explain the extensive enhanced prevalence of
allergy, which has doubled in the last decades to up to 25% of the population in west-
ern society and still seems to be rising. The increase has often been explained by a
decline in infection during childhood through increased hygiene, vaccinations and the
application of antibiotics. Other explanations refer to the general increase in smoking,
especially in women during pregnancy. The increase has also been suggested to result
from reduced incidence of breast feeding and from changes in general eating habits
(e.g. the increased consumption of exotic food products).
Recently, much attention has been paid to the ‘hygiene hypothesis’ to explain the
increase in allergy incidence. This hypothesis refers to the balance between various
cell types that form part of the immune system. Such a balance is the rule in healthy
individuals. However, in allergy sufferers this balance is disturbed. The basis of this
disturbance may be found in the loss of control of regulation in the various subsets of
cells (called T-cells) that are involved in the immune system. At present, three types of
T-cells have been distinguished: the T helper cells (Th1 and Th2), and the T regulator
cells (Treg cells). In the case of poor hygiene in combination with a high pathogen
load, including e.g. viruses, bacteria, protozoa or helminths, all three types of T-cells
will develop, with the Treg cells in a crucial role. So in the case of a high pathogen
load, a strong anti-inflammatory network is formed controlling both Th1 and Th2 cells.
In the case of limited contact with pathogens, Treg cells are absent, resulting in
uncontrolled Th1 or Th2 responses, including the increased occurrence of auto-
immune diseases (Th1 related diseases, like diabetes Type 1, rheumatoid arthritis,
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multiple sclerosis) and allergies (Th2 related diseases) (Stolte et al., 2002; Yazdan-
bakhsh et al., 2002). 
The patients’ point of view
The most common examples of IgE-mediated responses are rhinitis, asthma, eczema
and food allergies. 
Allergic rhinitis may be chronic or recurrent, and can occur seasonally or continu-
ously. Since the beginning of the 20th century the frequency of hay fever has
increased from 1% to an overall prevalence in the general population of about 15–20%
today. In many patients suffering from hay fever, the oral allergy syndrome (OAS) will
also develop after eating fresh fruits and vegetables due to IgE-mediated cross-reactivi-
ty resulting from similar proteins being present in both foods and pollen. A clear
example is allergy to apple (and other fruits from the Rosaceae family) and to vegeta-
bles from the Umbelliferae family (e.g. celery). These allergies arise from the presence
of proteins in these foods that are homologous to the major allergen in birch pollen
(Bet v 1) (Breiteneder & Ebner, 2000; Mills et al., 2003). 
Allergic rhinitis is under-diagnosed and thus under-treated. It is also considered to
be a trigger for the development of allergic asthma. In the 1980s the prevalence of
asthma has approximately doubled. A high prevalence occurs during the first years of
childhood but there is also a tendency towards increasing prevalence with growth into
adulthood.
During recent decades atopic dermatitis (eczema) has increased considerably espe-
cially in children under the age of seven. In some populations the prevalence among
children can reach levels of almost 25%. These children are at high risk of developing
respiratory symptoms in later years. There is convincing evidence suggesting that
atopic dermatitis will specifically become a major health problem for individuals born
after 1980. 
As for food, there is increasing public awareness that many foods cause allergy.
Examination of patients shows that about 1–2% of adults, and 6–8% of children suffer
from true food allergy. The major foods that cause allergies worldwide are cow’s milk,
chicken eggs, soya beans, nuts (especially groundnut), wheat, fish and shellfish. In
Europe, the relevance of soya beans and wheat to IgE-mediated food allergies is not yet
well established. True food allergy is often confused with different forms of food intol-
erance or sensitivity. Some food sensitivities result indirectly from disorders of the
digestive tract or from medical drug treatment. Other food sensitivities result from
toxic compounds in the food. In general, it is estimated that roughly 20% of all
adverse reactions to food are caused by true immuno-pathologic food allergy. 
The impact of having an allergy on the quality of life is considerable. Especially
food allergy can isolate people as the patient must avoid eating foods that contain the
allergens. In daily practice this can create various problems. Children’s parties, out-
door eating and many social activities related to work make it difficult to strictly
comply with the dietary rules. Several patients can even suffer from allergies to more
than one food. Many common allergenic food ingredients are also present in foods as
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hidden components. A clear example is gluten causing coeliac disease (CD). CD can
best be treated with a lifelong, strict gluten-free diet. In theory, this means refraining
from all foods derived from wheat, rye or barley. However, in practice, this apparently
straightforward solution meets with significant difficulties. Most modern foods are
processed and even products that appear to be safe to CD patients – such as oats – are
actually often unsafe because they are routinely contaminated with gluten from other
sources. Sauces, meat products, sweets, mayonnaise, medicinal drugs, coatings, glues,
shampoos and other cosmetics, can also contain gluten. Until recently, the ingredient
declaration list on food products did not need to indicate the full composition of
complex ingredients if they comprised less than 25% of the product. This 25% rule has
now been abolished and has been replaced by new labelling guidelines (Directive
2000/13/EC and amended by Directive 2003/89/EC) (Anon., 2003). This makes it
obligatory for all ingredients to be indicated on the label, to ensure that consumers
suffering from food allergies are fully informed. Nevertheless, even if a complex prod-
uct contains gluten at just a fraction of 1%, the food in question must still be avoided
by CD sufferers. Such is their sensitivity to gluten. This creates huge problems for
such patients when the relevant information on the declaration list is incomplete.
Moreover, some ingredient lists now indicate ‘may contain gluten’, ‘may contain nuts’,
‘may contain traces of …’. Unfortunately, such indications are generally a precaution-
ary measure taken to protect the producer but give rise to uncertainty in patients who
are allergic, and consequently these products are also avoided even though they may
actually be safe.
Other food allergies (e.g. to groundnut, hazelnut, shellfish) can be extremely seri-
ous and can cause a life-threatening anaphylactic shock that may lead to a significant
fear of food with psychologically aberrant behaviour as a result. This may occur in
adult patients, in parents of food-allergic children and even in the children themselves.
The effect of ‘eating differently’ may also create psychological problems, especially in
young adolescents who are afraid to loose contact with or to become alienated from
their peer group. 
A different problem relates to diagnosis. Timely diagnosis will prevent the occur-
rence of many physical and psychological problems. This becomes especially clear in
the case of CD, which can result in various vague but serious complaints that are often
not immediately recognized as being caused by this disease. Many examples are
known of patients who have only been diagnosed in later life and who became symp-
tom-free when using a gluten-free diet, but till then had been living a life of consider-
ably reduced quality. 
The economics of allergy 
Preventive care is considered a key factor in realizing health benefits. Prevention of
allergy in early childhood may provide a good possibility to reduce the ‘allergic march’,
i.e., the development of allergy in further life, in two possible ways: extension of sensi-
tivity towards other allergens, and intensifying symptoms. Consequently, the main
focus in allergy prevention should be directed towards young children at risk. Howev-
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er, the majority of current national health care programmes is still directed towards
medical care instead. Assessment of the major economical, allergy-related aspects for
society and individual patients takes account of the costs of medical care. An addition-
al economic factor is the size and potential of the markets for medical and dietary
products. But this aspect will not be elaborated here. 
Searching current literature reveals that little attention has been paid to the true
economic consequences of allergies. This is all the more remarkable since about 25%
of the European population suffers from some form of allergy. One of the few reliable
sources is the European Allergy White Paper (Anon., 1997; 1999). At the macro-
economic level, both direct and indirect costs have been distinguished. Direct costs are
the travel and treatment costs made by patients visiting and being treated by GP’s and
hospital specialists, as well as the cost of medicines. Such costs are reasonably well
quantifiable. Indirect costs, which are much less easily quantifiable, include e.g.
reduced productivity of less healthy workers, extra sick-days and increased time need-
ed for shopping. Direct plus indirect annual costs have been estimated for Western
Europe to be about 45 billion € (price level 2004) (Anon., 1997; 1999). Correspond-
ingly, these annual costs are about 2 billion € for a small country like the Netherlands.
The direct costs also include, amongst other, the costs of specific dietary products. But
not included are the costs that allergy patients are faced with because they often
require more expensive or more specialized products that are not designated as dietary
and thus are not covered by health care insurance. 
Genetic predisposition is a relevant factor in allergy. Children from parents with
allergy have an increased risk of becoming allergic too. For this reason the ‘Voedings-
centrum’ (Centre for Human Nutrition) in the Netherlands has proclaimed the
‘National standard’, indicating that children (babies) who are at risk on the basis of
family history, become eligible for preventive measures. This concerns 10–15% of
Dutch new-borns. Mother’s milk for six months is generally the most obvious food for
such babies but in specific cases, however, breast-feeding is not possible, and bottle-
feeding is necessary. In such cases, bottle-feed based on hypoallergenic protein
hydrolysate is advised. The additional costs of this hypoallergenic bottle-feed are 50%.
Currently, the Dutch market for hypoallergenic bottle-feed is only 3%, whereas this
market is much larger in neighbouring countries.  
Another example relates to CD. The total additional costs of gluten-free food prod-
ucts for diagnosed CD patients in the Netherlands have been estimated at 9 million €
annually, or € 1200 per patient per year (Netherlands Coeliac Disease Society; person-
al communication). However, since only 10% of the total Dutch CD patient population
has been diagnosed, these costs comprise a potential annual market for gluten-free
food products of 90 million €. Worldwide this amounts to 3.5–4 billion € for gluten-
free dietary products alone. 
As mentioned above, because of under-diagnosis, misdiagnosis and untimely late
diagnosis of allergy, physical and psychological problems will cause a variety of direct
medical (e.g. hospital uptake) and indirect societal (non-attendance at school and at
work) costs. The costs of medicines to treat allergies are reimbursed by health care
insurance companies, whereas the additional costs for hypoallergenic (bottle) food and
gluten-free food products – being the only remedy to cure CD patients – are not and
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have to be paid by the patient. This situation is different in EU countries like the UK,
France, Italy, Greece, Ireland and Sweden, where patients are reimbursed to compen-
sate for the additional costs. Next to a role of the national government, e.g. concerning
reimbursements for dietary products, there is also a significant societal role for the
food industry in giving a much higher priority to allergy prevention. 
Research on allergy prevention
The complexity of the allergy problem has been recognized in the Netherlands and
recently the Board of Directors of Wageningen University and Research Centre (WUR)
funded an extensive multidisciplinary research programme on various areas related to
allergy prevention. Allergy prevention can take place at various levels. In the pre-
medical phase the focus is directed towards prevention of sensitization. Secondary
prevention aims to stop further progression of the hypersensitivity through avoidance
of contact with the allergen and changing the patient’s life style. In the medical phase,
tertiary prevention is directed towards symptom fighting. In Wageningen most atten-
tion is being focused on allergy prevention in the pre-medical phase. Plant Research
International already ran a programme on apple allergy, funded by the Dutch Ministry
of Agriculture, Nature and Food Quality. This project ran parallel to an extensive EU
project on allergies to fresh fruits and vegetables (Gilissen, 2001). This research is
aimed at secondary prevention, i.e., development of strategies to reduce the incidence
of these types of allergy. Apple allergy develops in north-west Europe in individuals
that already suffer from hay fever caused by birch pollen. One of the proteins in this
pollen (Bet v 1) causes sensitization in susceptible individuals. Due to cross-reactivity
with similar proteins present in fresh food products like apple, cherry, hazelnut and
celery, these individuals become allergic and present oral allergy syndrome symptoms
(OAS). The relevant protein in apple is called Mal d 1, which is the major apple aller-
gen. Further research concerns (1) the selection of low-allergenic apple cultivars, (2)
the localization of the genes for Mal d 1 (and other apple allergens; Gao et al., unpub-
lished results; Gao et al., 2005) on the molecular genetic map of apple, and (3) the
knock-out of the expression of the Mal d 1 gene (Gilissen et al., 2005). In addition,
Plant Research International has a second research line directed to wheat gluten and
CD. 
Currently, governmental policy places much emphasis on health, food safety and
quality of life in response to major societal developments and needs. Wageningen
University and Research Centre has taken up this point and has enabled the establish-
ment of a unique infrastructure, the Allergy Consortium Wageningen (ACW) as a
virtual expertise centre with a major focus on research and education on allergy
prevention. The five Wageningen Science Groups (focusing on plant, animal, food
technology, green environment and societal research) are involved. This enables a
strong integration and co-ordination of both research and education. Five research
fields have been identified that will be covered by integrated research activities, each
steered by at least two Science Groups. Existing collaborations with medical institu-
tions (University Medical Centre-Utrecht, Leiden-University Medical Centre, Sanquin
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Blood Supply, and various hospitals and medical laboratories) will be further extended
within ACW. Five research fields have been identified and for each a PhD student
started in 2004. The research fields are:
1. Allergens in the green environment;
2. Stability of allergens in the food production chain;
3. Consumption patterns and the development of food allergy;
4. Wheat gluten and coeliac disease;
5. Novel foods and allergy concerns. 
Allergens in the green environment
Allergens in the green environment, or aeroallergens, are proteins that result in respi-
ratory complaints. About 10% of the population in north-west Europe suffers from hay
fever due to sensitization to pollen from birch and related tree species (Fagales). This
disease may develop into asthma and – because of cross-reactivity – the occurrence of
food allergy to fresh fruits and vegetables is a commonly related phenomenon. An
inventory will be made of the distribution of Fagales species in the Netherlands and in
the rest of Europe through molecular and genomics approaches with a focus on differ-
ences in allergenicity. The objective is identification or production – through genetic
modification techniques – of hypoallergenic genotypes for planting in the urban envi-
ronment. The societal component of this study involves the human attitude towards
plantations of genetically modified trees with beneficial characteristics, and the devel-
opment of an advisory strategy for local and national governments on urban design of
the green environment.
Stability of allergens in the food production chain 
A ubiquitous group of plant allergens belongs to the so-called Pathogenesis-Related
(PR)-proteins. Although these allergens bear many structural resemblances, they
behave differently in the food production chain. In particular, some appear to be very
stable and are therefore difficult to eliminate through processing. The objectives of
this research project is to identify the relationship between the molecular structure of
a number of Bet v 1 analogues from different fruit and vegetable species, to study their
stability in the food production chain, especially during the various steps of food
processing, and to investigate their possible allergenicity. The stability will be meas-
ured using both cellular and immunological techniques. 
Consumption patterns and the development of food allergy 
Allergies originate from interactions between the genetic background of the individual
and environmental factors. Allergic sensitization generally occurs at a young age, but
the disease can last a lifetime showing phase-wise changes in disease expression and
severity. In this project, a study will be made of the indicative and predictive value of
immuno-pathological markers obtained from human genomics information. The focus
will be on hay fever. A survey will be made of environmental, lifestyle and food intake
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variables to develop effective coping strategies applicable to the prevention of hay
fever. In addition, the economic impact of hay fever will be analysed.
Wheat gluten and coeliac disease 
Up to the present, elimination of gluten intake is the only option to prevent coeliac
disease (CD). However, not all gluten proteins and wheat cultivars appear to be equally
toxic. This creates possibilities to eliminate toxic gluten from wheat while maintaining
its necessary industrial qualities. To this end a genomics approach will be used.
Gluten genes form a large gene family. These genes and their alleles will be isolated
and sequenced from diploid (ancestral species), tetraploid (pasta wheats) and hexaploid
(bread wheats) genotypes. The proteins coded by these genes will then be used to
study their toxicity. In addition, the toxicity profile of individual wheat species and
cultivars will be examined. The ultimate goal of this research programme is the
improvement of the ‘quality of life’ of CD patients by enabling the development of
novel low-toxic wheat cultivars and food products. 
Novel foods and allergy concerns  
Modified eating habits, resulting in the introduction of new allergens into the daily
diet, have been identified as one of the causes of the increase in occurrence of allergy
during the last decades. Relevant EU-regulation is being developed to control the safe-
ty of novel foods. Testing the presence of allergens is relatively easy in genetically
modified (GM) novel foods, but is much more difficult in novel non-GM foods (like
exotic fruits, nuts and vegetables). This project involves research on the societal impact
of the introduction into the western diet of new products containing potential aller-
gens. Furthermore, the consumer’s perception of the acceptability of various scientific
and technological approaches to reduce food allergy will be studied. Such a study will
be carried out using patient and non-patient groups and will be supplemented with
stakeholder analysis. Retrospective (kiwi allergy) and prospective (GM StarlinkTM
maize) studies on historical, social, clinical, legal and communicational aspects will be
analysed in order to enable the development of allergy prevention strategies in food
production chain management. Government and the food industry are the main target
stakeholders to advise about the outcomes of this programme. 
Discussions on statements
A number of (provocative) statements were made during the recent workshop and
presented for discussion. A brief summary of these statements and the responses
from the different attendee groups is given below.
Statement 1. Allergy is a prosperity-related disease.
Some participants ascribed the increase of allergy during the last decades to improved
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diagnostics and to the obvious decrease in child death from other diseases. Others
strongly opposed this opinion and stated that the increase of allergy has been demon-
strated on the basis of solid scientific data. Solutions for allergy prevention should be
searched for in better modulation of the immune system, changing food consumption
patterns and changing life styles, rather than in reducing prosperity or omitting vacci-
nation of children. The composition of the intestinal flora may strongly influence the
immuno-regulatory network in the human body. Changing food consumption pattern
also appears to change the intestinal flora. Other treatments for tertiary prevention
include medical therapies like vaccination with allergens (hyposensitization), anti IgE
therapies, and the application of cytokine inhibitors. There was no unanimity on a
medical approach in the audience.
Statement 2. Prevention at the start of the health care chain will yield the
largest health profits/benefits.
Everybody agreed on this statement. However, in practice, only 2% of governmental
health care funds is dedicated to allergy prevention whereas 98% is spent on treat-
ment. Diagnosis and cure continue to have highest priority. Primary and secondary
prevention are nevertheless considered as being most relevant. Avoiding contact with
allergens prevents sensitization as well as further development of the allergic disease,
especially in babies. It was proposed that the focus should even be directed towards
prevention of contact in utero. Saving children from allergy will increase their quality
of life considerably. In the future, the possible development of gene passports may be
helpful in identifying the type of allergy an embryo or young baby may become
susceptible to. At that early age, a primary prevention programme could then be initi-
ated. If necessary, after maturation of the immune system, the child can be hyposensi-
tized using vaccination with the relevant allergen(s).
Statement 3. Birch pollen is the main cause of hay fever, allergic asthma and
several pollen-related food allergies; in the Netherlands, all birch trees should
therefore be eliminated from the urban environment. 
Some participants agreed with comments like: “the best birch is a plastic birch”, while
others disagreed because birch is endemic and impossible to eradicate. It is unclear
whether patients suffer from the pollen of the birch tree in their garden or from pollen
that hails from a much greater distance, e.g. Scandinavia. Analogous to an increase of
cypress allergy as the result of increasing cypress planting in gardens, the impact of
the garden birch is considered to be significant. Discussion demonstrated the need for
improved communication between scientists and responsible local and national
authorities. Prevention might be assisted by planting birch cultivars that are selected
as being hypoallergenic or male sterile (natural non-pollen producers, or developed
through genetic modification).
Statement 4. The niche market for hypoallergenic products is too small and
too fragmentary for diet food producers to get any return on investment.
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The food industry agreed with this statement. If a food company plays a major role in
the food market, it is felt as a commitment to their clients that it should also produce
dietary products. This makes the development of hypoallergenic food products indus-
try-driven and fragments the market. On the other hand, offering food specialities, just
like hypoallergenic products, may distinguish the various players in the market.
Although hypoallergenic foods touch a public health problem, and the production of
such foods might be government-driven, so far stimulation from government is mini-
mal. Furthermore, there remains the fundamental desire from industry for research
on whether prevention of the presence of allergens in baby foods may also inhibit the
development of allergies in later life. A different item relates to the current food prod-
ucts that are becoming more and more unreliable for allergic patients due the use of a
myriad of supplements and additives, which hampers the purchase of foods that are
safe for allergy sufferers. An example is the coating of potato chips with gluten to stick
on the paprika powder flavouring. In general, such cases can result in ‘may contain’
labelling by companies of such products, to avoid damage claims. To improve this situ-
ation, a re-evaluation of the production chain of complex food products is needed,
starting at the level of primary production, including the processing steps and ending
in clear labelling to inform the consumer. However, this inevitably will increase the
price of these products. 
Statements 5 and 6. Allergy is a medical rather than an agricultural problem,
and The interest of politicians in allergy and allergy prevention has to
increase enormously in the coming years.
These statements were taken together. The common feeling was that allergy is not
only a medical problem, but strongly links agriculture, food production and process-
ing, the living environment and health. Integrated research across these fields is
essential. The approach of the Allergy Consortium Wageningen is a good example that
deserves strong support. In addition, a proposed ‘Ministry of Research’ would be a
solution to establish more easily cross-links between the relevant parties.
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